MCL-1 inhibitor
MCL-1 inhibitor has been studied in 2 papers since 2022: none in people yet, 1 in animals, 1 in cells. The research so far is in animals and cells. The newest paper, Dec 23, 2022: “Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression”.
2 papers study itUpdated
- Animals1
- Cells1
Latest
Nature Communications
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Experiments in miceInterventions
Aging
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Experiments in human cellsInterventions